Dexcor Specialities Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2020
- Revenue Growth 62.58%
- Profit Growth 1.56%
- Ebitda 28.27%
- Net Worth 64.61%
- Total Assets -12.66%
About Dexcor Specialities
Dexcor Specialities Private Limited (DSPL) is a Private Limited Indian Non-Government Company incorporated in India on 01 April 2013 and has a history of 11 years and ten months. Its registered office is in Vadodara, Gujarat, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shital Tumdam and Kishan Raval serve as directors at the Company.
Company Details
-
Location
Vadodara, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100GJ2013PTC074254
-
Company No.
074254
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Apr 2013
-
Date of AGM
31 Dec 2020
-
Date of Balance Sheet
31 Mar 2020
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Dexcor Specialities Private Limited offer?
Dexcor Specialities Private Limited offers a wide range of products and services, including Electronics Manufacturing Service, PCB Fabrication Service, Power Supply Systems, DC Power Supply.
Who are the key members and board of directors at Dexcor Specialities?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shital Tumdam
|
Additional Director | 16-Feb-2021 | Current |
|
Kishan Raval
|
Director | 28-Jul-2020 | Current |
Financial Performance of Dexcor Specialities.
Dexcor Specialities Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 62.58% increase. The company also saw a slight improvement in profitability, with a 1.56% increase in profit. The company's net worth Soared by an impressive increase of 64.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dexcor Specialities?
In 2020, Dexcor Specialities had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Vipol Specialities Private LimitedKishan Raval is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dexcor Specialities?
Unlock and access historical data on people associated with Dexcor Specialities, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dexcor Specialities, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dexcor Specialities's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
